Participation in colorectal cancer screening among Chinese Americans

Asian Pacific Journal of Cancer Prevention

Volumn 7, Issue 4, 2006, Pages 645-660

  Yip, Mei Po ^a   Tu, Shin Ping ^a   Chun, Alan ^b   Yasui, Yutaka ^c   Taylor, Victoria M ^d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Public Health Seattle and King County   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Chinese americans; Colorectal cancer screening; Prevention programs

Indexed keywords

AGED; ARTICLE; ASIAN AMERICAN; CHI SQUARE DISTRIBUTION; CHINA; COLONOSCOPY; COLORECTAL TUMOR; CULTURAL FACTOR; ETHNOLOGY; FEMALE; HUMAN; INTERVENTION STUDY; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; OCCULT BLOOD; PATIENT PARTICIPATION; RETROSPECTIVE STUDY; SIGMOIDOSCOPY; STATISTICS; UNITED STATES;

ACCULTURATION; AGED; ASIAN AMERICANS; CHI-SQUARE DISTRIBUTION; CHINA; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTERVENTION STUDIES; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT PARTICIPATION; RETROSPECTIVE STUDIES; SIGMOIDOSCOPY; UNITED STATES; WASHINGTON;

EID: 33947500451     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Araujo SE, Alves PR, Habr-Gama A (2001). Role of colonoscopy in colorectal cancer. Rev Hosp Clin Fac Med Sao Paulo, 56, 25-35.
2. American Cancer Society (2002). Detailed guide: Colon and rectal cancer screening.www.cancer.org.
3. Bernstein LA, Wu H (1998). Colon and rectal cancer among Asian Americans and Pacific Islanders. Asian Am Pac Isl J Health, 6, 184-200.
4. Blair KA (1998). Cancer screening in older women: a primary care issue. Cancer Pract, 6, 217-22.
5. Blom JA, Liden A, Nilsson J, et al (2004).Colorectal cancer screening with flexible sigmoidoscopy-participants' experiences and technical feasibility. Eur J Surg Oncol, 30, 362-9.
6. Center for Disease Control (2003). Colorectal caner screening test use among persons aged >50 years--United States, 2001. MMWR Morb Mortal Wkly Rep, 52, 193-6.
7. Center for Disease Control (1999). Screening for colorectal cancer-United States. MMWR Morb Mortal Wkly Rep, 48, 116-21.
8. Cheng TI, Wong JM, Hong CF, et al (2002). Colorectal cancer screening in asymptomaic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests. J Formos Med Assoc, 101, 685-90.
9. Hardcastle JD, Chamberlain JO, Robinson MH, et al (1996).Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet, 348, 1472-7.
10. Hawley ST, Vernon SW, Levin B, Vallejo, B (2004).Prevalence of colorectal cancer screening in a large medical organization. Cancer Epidemiol Biomarkers Prev, 13, 314-9.
11. Honda K (2004).Factors associated with colorectal cancer screening among the US urban Japanese population. Am J Public Health, 94, 815-22.
12. Ioannou GN, Chapko MK, Dominitz JA (2003).Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol, 98, 2082-91.
13. Jemal A, Siegel R, Ward E, et al (2006).Cancer statistics: 2006. CA Cancer J Clin, 56, 106-30.
14. Jenkins CN, McPhee SJ, Bird JA, Bonilla NT (1990). Cancer risks and prevention practices among Vietnamese refugees. West J Med, 153, 34-9.
15. Juon HS, Han W, Shin H, Kim KB, Kim MT (2003).Predictors of older Korean Americans' participation in colorectal cancer screening. J Cancer Educ, 18, 37-42.
16. Kim K., Yu ES, Chen EH, et al (1998).Colorectal cancer screening: knowledge and practices among Korean Americans. Cancer Pract, 6, 167-75.
17. Kronborg OC, Fenger C, Olsen J, Jorgensen OD, Sondergaard O (1996). Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet, 348, 1467-71.
18. Lee MM, Lee F, Stewart S, McPhee S (1999). Cancer screening practices among primary care physicians serving Chinese Americans in San Francisco. West J Med, 170, 148-55.
19. Lewis JD, Asch DA (1999). Colorectal cancer screening with sigmoidoscopy: primary care issues. LDI Issue Brief, 4, 1-4.
20. Lieberman DA, Weiss DG, Bond JH, et al (2000).Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med, 343, 162-8.
21. Mandel JS, Church TR, Ederer F, et al (1999).Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst, 91, 434-7.
22. Mandel JS,Church TR, Bond JH, et al (2000). The effect of fecal occult-blood testing on the incidence of colorectal cancer. NEJM, 343, 1603-7.
23. Maxwell AE, Bastani R, Warda US (2000). Demographic predictors of cancer screening among Filipino and Korean immigrants in the United States. Am J Prev Med, 18, 62-8.
24. Patel P, Forjuoh SN, Avots-Avotins A, Patel T (2004). Identifying opportunities for improved colorectal cancer screening in primary care. Prev Med, 39, 239-46.
25. Pignone M, Saha S, Hoerger T, Mandelblatt J (2002).Costeffectiveness analyses of colorectal cancer screening: a systematic review for the US Preventive Services Task Force. Ann Intern Med, 137, 96-104.
26. Ruffin MT, Gorenflo DW, Woodman B (2000). Predictors of screening for breast, cervical, colorectal, and prostatic cancer among community-based primary care practices. J Am Board Fam Pract, 13, 1-10.
27. Schroy PC, Heeren T, Bliss CM, et al (1999).Implementation of on-site screening sigmoidoscopy positively influences utilization by primary care providers. Gastroenterology, 117, 304-11.
28. Seeff LC, Nadel MR, Klabunde CN, et al (2004). Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer, 100, 2093-103.
29. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS (1992). A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med, 326, 653-7.
30. Subramanian S, Klosterman M, Amonkar MM, Hunt TL (2004). Adherence with colorectal cancer screening guidelines: a review. Prev Med, 38, 536-50.
31. Sun WY, Basch CE, Wolf RL, Li XY (2004). Factors associated with colorectal cancer screening among Chinese-Americans. Prev Med, 39, 323-9.
32. Swan JN, Breen N, Coates RJ, Rimer BK, Lee NC (2003). Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer, 97, 1528-40.
33. Tang TS, Solomon LJ, McCracken LM (2001). Barriers to fecal occult blood testing and sigmoidoscopy among older Chinese-American women. Cancer Pract, 9, 277-82.
34. Tu. SP, Taylor V, Yasui Y, et al (2006). Promoting culturally approriate colorectal cancer screening through a health educator: a randomized trial. Cancer, 107, 959-66.
35. US Department of Health and Human Services (2002). Healthy people 2010: National health promotion and disease prevention objectives. Washington (DC): US.
36. US Department of Health and Human Services (2005). The Guide to Clinical Preventive Services 2005: Recommendations of theUS Preventive Services Task Force.
37. US Preventive Services Task Force (2002). Screening for Colorectal cancer screening: recommendation and rationale.
38. Walsh JM, Kaplan CP, Nguyen B, et al (2004). Barriers to colorectal cancer screening in Latino and Vietnamese Americans. Compared with non-Latino white Americans. J Gen Intern Med, 19, 156-66.
39. Walsh JM, Posner SF, Perez-Stable EJ (2002). Colon cancer screening in the ambulatory setting. Prev Med, 35, 209-18.
40. Walsh JM, Terdiman JP (2003). Colorectal cancer screening: scientific review. JAMA, 289, 1288-96.
41. Ward E, Jemal A, Cokkinides V, et al (2004). Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin, 54, 78-93.
42. Whittemore AS, Wu-Williams AH, Lee M, et al (1990). Diet, physical activity, and colorectal cancer among Chinese in North America and China. J Natl Cancer Inst, 82, 915-26.
43. Yu HR, Harris R, Gao Y, et al (1991). Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States. Int J Epidemiol, 20, 76-81.
44. Zapka JG, Puleo E, Vickers-Lahti M,et al (2002). Healthcare system factors and colorectal cancer screening. Am J Prev Med, 23, 28-35.